Added to YB: 2023-12-15
Pitch date: 2023-12-15
RPHM [bullish]
Reneo Pharmaceuticals, Inc.
+33.82%
current return
Author Info
Clark Street Value is a special sits/event-driven investor. Sign up for the newsletter.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases.
Market Cap
$55.8M
Pitch Price
$13.60
Price Target
N/A
Dividend
N/A
EV/EBITDA
0.35
P/E
-0.77
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
Reneo Pharmaceuticals: Phase 2 Study Misses, Pre-SA Broken Biotech
A summary for this pitch has not been created yet.
Read full article (1 min)